| Rule |
|---|
|
Rule 4729-8-01 | Overdose reversal drugs.
Pursuant to section 4729.01 of the Revised Code, the state board of pharmacy hereby designates the following dangerous drugs, which have been approved by the federal food and drug administration for the reversal of a known or suspected opioid-related overdose, as overdose reversal drugs: (A) Naloxone; and (B) Nalmefene. Last updated August 5, 2025 at 7:55 AM Supplemental Information |
|
Rule 4729-8-02 | Approval of instruments to reduce drug poisoning.
(A) Pursuant to sections 4729.261 and 2925.14 of the Revised Code, the state board of pharmacy hereby determines that drug testing strips and reagent kits are effective at reducing drug poisoning by determining the presence of the following compounds: (1) Fentanyl and fentanyl-related compounds; (2) Xylazine; (3) Medetomidine; (4) Benzimidazole-opioids or nitazenes; and (5) Benzodiazepines and benzodiazepine-related compounds. (B) The board may approve additional instruments via resolution. The board shall consider the following when deciding on whether to approve additional instruments: (1) Drug poisoning data, including data from other states; (2) Reports provided by established forensic laboratories as defined in rule 4729:9-1-01 of the Administrative Code; (3) Reports from harm reduction organizations operating within the state; (4) Any other information as determined by the board. (C) A resolution issued in accordance with paragraph (B) of this rule shall exempt the instrument from the definition of drug paraphernalia under section 2925.14 of the Revised Code. (D) This rule shall be updated periodically to reflect any new instruments approved via paragraph (B) of this rule. (E) In accordance with section 4729.261 of the Revised Code, none of the instruments approved pursuant to this rule shall measure the proportion of a controlled substance within the total mixture. Last updated November 5, 2025 at 9:10 AM Supplemental Information |